MILAN, Mar 16, 2017 (BUSINESS WIRE) — Newron Pharmaceuticals S.p.A. (“Newron”), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today announces that Ravi Anand, M.D.